Jens Baas, the CEO of the Techniker Krankenkasse, is advocating for comprehensive reforms within Germany’s healthcare system. Speaking to Spiegel, Baas noted that Germany spends significantly more on healthcare relative to its gross domestic product than any other country in Europe. He dismissed arguments suggesting the system needs further massive cash infusions, labeling such notions as “utter nonsense”.
Regarding the proposals put forward by the government commission to fund the healthcare system, Baas expressed general agreement but advised caution. He stressed that what is presented are merely suggestions, and the final legislation will be the deciding factor. He considered the opposition to the 66 reform proposals-which would involve a relief of €42 billion-as predictable, suggesting that opposition arguments are based more on emotion than factual evidence, with everyone claiming to care solely for patient welfare.
Looking ahead, Baas warns that without structural reforms, the system is heading toward a dramatic tipping point, potentially escalating to a contribution rate of 20 percent. Addressing Federal Health Minister Nina Warken, he urged her to maintain her firm stance despite expected pressure, stating that her success in implementing necessary measures, even if painful, depends on her courage.
Baas was particularly critical of the pharmaceutical industry. He dismissed the industry’s threat to withdraw from the German market if drug prices fall, calling it a “mere threat” and “absolute nonsense”. He argued that because Germany is one of the world’s largest markets and already commands high prices, the supposed leverage for such coercion simply does not exist.
Furthermore, Baas criticized the lack of a “counterbalance” to the pharmaceutical industry’s power, noting that health insurance providers lack equal bargaining power in discussions with the industry to set reasonable prices, and that the politicians often lack the necessary courage. He observed that the pharmaceutical industry presents itself with a mix of seemingly research-focused behavior and veiled threats, which causes the argument about Germany’s industrial location to carry too much weight domestically, even reaching the Chancellery.